Sotagliflozin FDA approval date

The FDA approved Sotagliflozin (SAR439954/LX4211) on 26 May 2023.

FDA approval date
26 May 2023

Drug identity checked against registry records

Also recorded as SAR439954/LX4211

Included trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2023-05-26DaySotagliflozinFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA216203", "applicant_as_listed_by_fda": "LEXICON PHARMS INC", "brand_names": ["INPEFA"], "active_ingredients": ["SOTAGLIFLOZIN"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20230526", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026